What is Aclaris Therapeutics's price / book?

Aclaris Therapeutics (ACRS) reported price / book of 3.2× in Q1 2026.

How has Aclaris Therapeutics's price / book changed year-over-year?

Aclaris Therapeutics's price / book increased by 175.2% year-over-year, from 1.1× to 3.2×.

What is the long-term trend for Aclaris Therapeutics's price / book?

Over 5 years (2020 to 2025), Aclaris Therapeutics's price / book has grown at a -21.4% compound annual growth rate (CAGR), from 10.5× to 3.2×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Aclaris Therapeutics ACRS Price / book

Price / book at other companies

IncyteINCY

3.3×+0.1×

Corvus PharmaceuticalsCRVS

5.1×+0.7×

Avalo TherapeuticsAVTX

5×+4.3×

Shattuck Labs, Inc.STTK

4.8×+4.1×

Kymera TherapeuticsKYMR

4.4×+2.2×

CytomX TherapeuticsCTMX

3.2×+1.1×

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

market cap/total stockholders equity=3.2×

Based on the most recent quarter.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's price / book?: Aclaris Therapeutics (ACRS) reported price / book of 3.2× in Q1 2026.
How has Aclaris Therapeutics's price / book changed year-over-year?: Aclaris Therapeutics's price / book increased by 175.2% year-over-year, from 1.1× to 3.2×.
What is the long-term trend for Aclaris Therapeutics's price / book?: Over 5 years (2020 to 2025), Aclaris Therapeutics's price / book has grown at a -21.4% compound annual growth rate (CAGR), from 10.5× to 3.2×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.